Gene · 406901
Papers3,765
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,765
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Circular RNA SET domain protein 3 promotes nasopharyngeal carcinoma proliferation, cisplatin resistance, and protein kinase B / mammalian target of rapamycin pathway activation by modulating microRNA-147a expression. | Bioengineered | 2022 | 35196205 | PubTator, text mining | PubMed |
| The emerging role non-coding RNAs in B cell-related disorders. | Cancer Cell Int | 2022 | 35193592 | PubTator, text mining | PubMed |
| Oscillatory Behaviors of microRNA Networks: Emerging Roles in Retinal Development. | Front Cell Dev Biol | 2022 | 35186936 | PubTator, text mining | PubMed |
| Biomarker Landscape in Neuroendocrine Tumors With High-Grade Features: Current Knowledge and Future Perspective. | Front Oncol | 2022 | 35186729 | PubTator, text mining | PubMed |
| Identification of miRNAs involved in liver injury induced by chronic exposure to cadmium. | Toxicology | 2022 | 35183672 | PubTator, text mining | PubMed |
| Determining The Role of MicroRNAs in Self-Renewal, Metastasis and Resistance to Drugs in Human Gastric Cancer Based on Data Mining Approaches: A Systematic Review. | Cell J | 2022 | 35182058 | PubTator, text mining | PubMed |
| Selection of reference genes for quantitative analysis of microRNA expression in three different types of cancer. | PLoS One | 2022 | 35176014 | PubTator, text mining | PubMed |
| Identification of Ferroptosis-Related Biomarkers for Prognosis and Immunotherapy in Patients With Glioma. | Front Cell Dev Biol | 2022 | 35174152 | PubTator, text mining | PubMed |
| Construction of a circRNA-miRNA-mRNA network based on differentially co-expressed circular RNA in gastric cancer tissue and plasma by bioinformatics analysis. | World J Surg Oncol | 2022 | 35164778 | PubTator, text mining | PubMed |
| Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell Lines. | Int J Mol Sci | 2022 | 35163589 | PubTator, text mining | PubMed |
| The Role of Androgen Receptor and microRNA Interactions in Androgen-Dependent Diseases. | Int J Mol Sci | 2022 | 35163477 | PubTator, text mining | PubMed |
| Tumor-Derived Exosomes in Tumor-Induced Immune Suppression. | Int J Mol Sci | 2022 | 35163380 | PubTator, text mining | PubMed |
| Aberrant Methylation of 20 miRNA Genes Specifically Involved in Various Steps of Ovarian Carcinoma Spread: From Primary Tumors to Peritoneal Macroscopic Metastases. | Int J Mol Sci | 2022 | 35163224 | PubTator, text mining | PubMed |
| Current and New Challenges in the Management of Pancreatic Neuroendocrine Tumors: The Role of miRNA-Based Approaches as New Reliable Biomarkers. | Int J Mol Sci | 2022 | 35163032 | PubTator, text mining | PubMed |
| Use of Omics Technologies for the Detection of Colorectal Cancer Biomarkers. | Cancers (Basel) | 2022 | 35159084 | PubTator, text mining | PubMed |
| Crosstalk between Long Non Coding RNAs, microRNAs and DNA Damage Repair in Prostate Cancer: New Therapeutic Opportunities? | Cancers (Basel) | 2022 | 35159022 | PubTator, text mining | PubMed |
| Analysis of miRNAs Involved in Mouse Heart Injury Upon Coxsackievirus A2 Infection. | Front Cell Infect Microbiol | 2022 | 35155276 | PubTator, text mining | PubMed |
| The role of the microRNA regulatory network in Alzheimer's disease: a bioinformatics analysis. | Arch Med Sci | 2022 | 35154541 | PubTator, text mining | PubMed |
| Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from coronary artery disease. | J Cell Mol Med | 2022 | 35152560 | PubTator, text mining | PubMed |
| Construction and Comprehensive Analysis of a circRNA-miRNA-mRNA Regulatory Network to Reveal the Pathogenesis of Hepatocellular Carcinoma. | Front Mol Biosci | 2022 | 35141281 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406901/papers?page=50